블로그 · 최신 · 날짜 표기 · 출처 인용
GLP-1, 지금 — 2026년에 무엇이 바뀌었고 데이터는 무엇을 말하는가.
올해 사람들이 실제로 검색하는 질문에 먼저 답하는 설명으로, 각 글은 FDA 처방 정보와 동료 검토를 거친 임상시험에 근거합니다. 변하지 않는 기본 지식은 저희 GLP-1 가이드부터 시작하세요.
Microdosing GLP-1 in 2026
Microdosing GLP-1 medications is everywhere — but what does the evidence say? An honest look at what it means, why people do it, and what's known about safety.
Missed Your Wegovy Dose? (2026)
Missed a Wegovy shot? The '2-day' and '4-day' rules get confused online. Here's the FDA-label answer for Wegovy: when to take it late, and when to skip.
Oral GLP-1 Tracking in 2026
How the daily oral GLP-1 tablet schedule works, why the empty-stomach rule is non-negotiable, and what's worth tracking when your GLP-1 is a pill, not a shot.
Protein target on GLP-1 (g/kg), 2026 guide
How much protein should you aim for on a GLP-1? A source-backed look at targets in grams per kilogram, and how to hit the number when your appetite is low.
Semaglutide mg to Units (2026)
Converting a semaglutide dose from mg to insulin-syringe units? The answer depends on your vial's concentration — here's the arithmetic, and why charts are risky.
Zepbound Plateau at Week 12? (2026)
Stalled on Zepbound around week 12? Before assuming tirzepatide stopped working, check dose timing, steady state and titration stage — from the FDA label.
교육용 콘텐츠이며 의학적 조언이 아닙니다. 모든 게시물은 FDA 처방 정보와 인용된 임상시험을 바탕으로 작성됩니다. 작성 및 갱신 방식은 저희 편집 정책을 참고하세요.